4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001140361-08-021241
$NBYCIK 0001389545operating
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:37 PM ET
Size
5.9 KB
Accession
0001140361-08-021241
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Purchase
Common Stock
2008-09-11$1.95/sh+500$975→ 1,000 total(indirect: By Trust)
Holdings
- 135,000
Common Stock
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:37 PM ET
- Size
- 5.9 KB